Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 245  
 
REVIEW ARTICLE
Ahead of Print

Role of18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of breast carcinoma: Indications and pitfalls with illustrative case examples


1 Department of Radiology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
2 Department of Cyclotron and Radiopharmaceuticals, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

Correspondence Address:
Moheieldin M Abouzied,
Department of Radiology, King Faisal Specialist Hospital and Research Centre, Riyadh
Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/wjnm.WJNM_88_19

Whole-body18F-fluorodeoxyglucose positron emission tomography (PET) has been used extensively in the last decade for the primary staging and restaging and to assess response to therapy in these patients. We aim to discuss the diagnostic performance of PET/computed tomography in the initial staging of breast carcinoma including the locally advanced disease and to illustrate its role in restaging the disease and in the assessment of response to therapy, particularly after the neoadjuvant chemotherapy. Causes of common pitfalls during image interpretations will be also discussed.


Print this article
Search
 Back
 
  Search Pubmed for
 
    -  Abouzied MM
    -  Fathala A
    -  AlMuhaideb A
    -  Al Qahtani MH
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed13    
    PDF Downloaded5    

Recommend this journal